Henry Schein Stock Price, News & Analysis (NASDAQ:HSIC)

$69.52 +1.14 (+1.67 %)
(As of 02/19/2018 02:54 PM ET)
Previous Close$68.38
Today's Range$68.00 - $71.17
52-Week Range$63.01 - $93.50
Volume2.87 million shs
Average Volume2.06 million shs
Market Capitalization$10.91 billion
P/E Ratio20.03
Dividend YieldN/A
Beta1

About Henry Schein (NASDAQ:HSIC)

Henry Schein logoHenry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The technology and value-added services segment provides software, technology and other value-added services to healthcare practitioners. Its technology group offerings include practice management software systems for dental and medical practitioners and animal health clinics. The Company provides its services to dental practitioners and laboratories, animal health clinics and physician practices, as well as government and institutional healthcare clinics.

Receive HSIC News and Ratings via Email

Sign-up to receive the latest news and ratings for HSIC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment Wholesale
Sub-IndustryHealth Care Distributors
SectorMedical
SymbolNASDAQ:HSIC
CUSIP80640710
Phone631-843-5500

Debt

Debt-to-Equity Ratio0.30%
Current Ratio1.55%
Quick Ratio0.86%

Price-To-Earnings

Trailing P/E Ratio20.0345821325648
Forward P/E Ratio19.31
P/E Growth1.78

Sales & Book Value

Annual Sales$11.57 billion
Price / Sales0.94
Cash Flow$4.42 per share
Price / Cash15.74
Book Value$17.40 per share
Price / Book4.00

Profitability

Trailing EPS$3.47
Net Income$506.77 million
Net Margins4.52%
Return on Equity19.71%
Return on Assets8.09%

Miscellaneous

Employees21,000
Outstanding Shares156,950,000

Henry Schein (NASDAQ:HSIC) Frequently Asked Questions

What is Henry Schein's stock symbol?

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

When did Henry Schein's stock split? How did Henry Schein's stock split work?

Shares of Henry Schein split on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly minted shares were issued to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of Henry Schein stock prior to the split would have 200 shares after the split.

How will Henry Schein's stock buyback program work?

Henry Schein announced that its board has initiated a share buyback program on Tuesday, September 19th 2017, which authorizes the company to repurchase $400,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 6.3% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company's leadership believes its shares are undervalued.

How were Henry Schein's earnings last quarter?

Henry Schein, Inc. (NASDAQ:HSIC) posted its earnings results on Monday, November, 6th. The company reported $0.87 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.90 by $0.03. The company had revenue of $3.16 billion for the quarter, compared to analysts' expectations of $3.05 billion. Henry Schein had a net margin of 4.52% and a return on equity of 19.71%. The firm's revenue was up 10.3% on a year-over-year basis. During the same period in the prior year, the firm posted $0.84 EPS. View Henry Schein's Earnings History.

When will Henry Schein make its next earnings announcement?

Henry Schein is scheduled to release their next quarterly earnings announcement on Tuesday, February, 20th 2018. View Earnings Estimates for Henry Schein.

Where is Henry Schein's stock going? Where will Henry Schein's stock price be in 2018?

15 Wall Street analysts have issued 12-month price targets for Henry Schein's stock. Their forecasts range from $74.00 to $109.00. On average, they expect Henry Schein's stock price to reach $83.71 in the next year. View Analyst Ratings for Henry Schein.

What are Wall Street analysts saying about Henry Schein stock?

Here are some recent quotes from research analysts about Henry Schein stock:

  • 1. According to Zacks Investment Research, "Over the past three months, Henry Schein has underperformed the broader industry. The company witnessing year-over-year deterioration in gross and operating margin due to higher cost of sales and expenses continues to be a concern. This apart, competitive pricing remains another cause of concern. We are disappointed with the company’s lowering of the high end of the 2017 EPS guidance indicating a gloomy scenario ahead. On a positive note, balanced growth across all operating segments as well as the Henry Schein’s gains in the United States as well as overseas raise optimism. We are also positive about the company completing the buyout of Merritt Veterinary Supplies." (1/4/2018)
  • 2. Evercore ISI analysts commented, "HSIC continues to deliver consistent HSD to LDD EPS growth despite an operating environment that has been somewhat mixed, albeit North American Dental continues to show signs of recovery. With the acquisition engine still churning and an elevated level of buybacks, management has been able to deliver the type of TSR expected and thus the valuation remains notably elevated on an absolute basis (less so on a relative basis). While we also value consistency and predictability, we acknowledge we missed the November entry point (fears of US slowdown) and thus at current levels see risk / reward as more fully balanced (particularly with extra week headwind in 2017 + unfavorable Fx environment). Given this dynamic we reiterate our Hold rating and argue shares are now accurately pricing in the current operating environment. Thus we await another period of uncertainty prior to revisiting our long-term constructive view on shares." (2/21/2017)

Who are some of Henry Schein's key competitors?

Who are Henry Schein's key executives?

Henry Schein's management team includes the folowing people:

  • Stanley M. Bergman, Chairman of the Board, Chief Executive Officer (Age 67)
  • James P. Breslawski CPA, President, Director; Chief Executive Officer of Henry Schein Global Dental Group (Age 63)
  • Steven Paladino CPA, Chief Financial Officer, Executive Vice President, Director (Age 60)
  • Peter McCarthy, President of Global Animal Health Group (Age 57)
  • David C. McKinley, President of Corporate Commercial Development Group, Chief Commercial Officer (Age 64)
  • Bob Minowitz, President, International Dental Group, EMEA Region (Age 58)
  • Bridget A. Ross, President of Global Medical Group (Age 52)
  • Gerald A. Benjamin, Chief Administrative Officer, Executive Vice President, Director (Age 64)
  • Mark E. Mlotek, Chief Strategic Officer, Executive Vice President, Director (Age 61)
  • Karen N. Prange, Executive Vice President; Chief Executive Officer of Global Animal Health, Medical and Dental Surgical Group (Age 53)

Who owns Henry Schein stock?

Henry Schein's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.49%), Generation Investment Management LLP (7.03%), GENERATION INVESTMENT MANAGEMENT LLP (5.10%), GENERATION INVESTMENT MANAGEMENT LLP (5.10%), Mackenzie Financial Corp (3.84%) and Atlanta Capital Management Co. L L C (1.57%). Company insiders that own Henry Schein stock include Barry J Alperin, David Mckinley, Donald J Kabat, Gerald A Benjamin, James A Harding, Kurt P Kuehn, Lonnie Shoff, Lorelei Mcglynn, Louis W Sullivan, Mark E Mlotek, Michael Racioppi, Michael S Ettinger, Norman S Matthews, Paul Brons, Paul Rose, Peter M Mccarthy, Philip A Laskawy, Robert Minowitz and Steven Paladino. View Institutional Ownership Trends for Henry Schein.

Who sold Henry Schein stock? Who is selling Henry Schein stock?

Henry Schein's stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Bamco Inc. NY, Bowen Hanes & Co. Inc., Chevy Chase Trust Holdings Inc., Martingale Asset Management L P, Mountain Pacific Investment Advisers Inc. ID, Teacher Retirement System of Texas and APG Asset Management N.V.. Company insiders that have sold Henry Schein company stock in the last year include Barry J Alperin, Donald J Kabat, Gerald A Benjamin, James A Harding, Lorelei Mcglynn, Mark E Mlotek, Michael Racioppi, Michael S Ettinger, Paul Rose, Philip A Laskawy and Steven Paladino. View Insider Buying and Selling for Henry Schein.

Who bought Henry Schein stock? Who is buying Henry Schein stock?

Henry Schein's stock was purchased by a variety of institutional investors in the last quarter, including Generation Investment Management LLP, Mackenzie Financial Corp, Deutsche Bank AG, American Century Companies Inc., Two Sigma Advisers LP, Renaissance Technologies LLC, Kovitz Investment Group Partners LLC and AXA. View Insider Buying and Selling for Henry Schein.

How do I buy Henry Schein stock?

Shares of Henry Schein can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Henry Schein's stock price today?

One share of Henry Schein stock can currently be purchased for approximately $69.52.

How big of a company is Henry Schein?

Henry Schein has a market capitalization of $10.91 billion and generates $11.57 billion in revenue each year. The company earns $506.77 million in net income (profit) each year or $3.47 on an earnings per share basis. Henry Schein employs 21,000 workers across the globe.

How can I contact Henry Schein?

Henry Schein's mailing address is 135 DURYEA RD, MELVILLE NY, 11747. The company can be reached via phone at 631-843-5500 or via email at [email protected]


MarketBeat Community Rating for Henry Schein (HSIC)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  175 (Vote Outperform)
Underperform Votes:  343 (Vote Underperform)
Total Votes:  518
MarketBeat's community ratings are surveys of what our community members think about Henry Schein and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Henry Schein (NASDAQ:HSIC) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.402.432.432.40
Ratings Breakdown: 1 Sell Rating(s)
7 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
9 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $83.71$84.23$89.88$92.04
Price Target Upside: 22.34% upside16.76% upside28.33% upside3.00% upside

Henry Schein (NASDAQ:HSIC) Consensus Price Target History

Price Target History for Henry Schein (NASDAQ:HSIC)

Henry Schein (NASDAQ:HSIC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/15/2018JPMorgan Chase & Co.Reiterated RatingNeutral -> Neutral$79.00 -> $77.00LowView Rating Details
2/13/2018Leerink SwannReiterated RatingHoldHighView Rating Details
1/4/2018Evercore ISIInitiated CoverageOutperform -> Outperform$81.00MediumView Rating Details
12/27/2017Piper Jaffray CompaniesReiterated RatingBuy$78.00LowView Rating Details
12/8/2017Deutsche BankInitiated CoverageBuy -> Buy$79.00LowView Rating Details
12/6/2017Morgan StanleyDowngradeEqual Weight -> Underweight$88.00HighView Rating Details
11/28/2017Credit Suisse GroupReiterated RatingNeutral$87.50 -> $80.00LowView Rating Details
11/28/2017StephensInitiated CoverageEqual -> Equal Weight$76.00LowView Rating Details
11/7/2017Jefferies GroupLower Price TargetHold$89.00 -> $74.00N/AView Rating Details
11/7/2017Stifel NicolausLower Price TargetHold -> Hold$89.00 -> $77.00N/AView Rating Details
11/7/2017Craig HallumUpgradeHold -> BuyN/AView Rating Details
11/7/2017Royal Bank of CanadaLower Price TargetSector Perform -> Sector Perform$91.00 -> $82.00N/AView Rating Details
10/19/2017Robert W. BairdSet Price TargetBuy$95.00N/AView Rating Details
8/7/2017Northcoast ResearchUpgradeNeutral -> Buy$109.00HighView Rating Details
5/10/2017Barrington ResearchBoost Price TargetOutperform -> Outperform$98.00 -> $99.00LowView Rating Details
1/10/2017GabelliUpgradeHold -> Buy$104.00N/AView Rating Details
10/11/2016Goldman Sachs GroupUpgradeNeutral -> Buy$92.50N/AView Rating Details
9/12/2016Bank of AmericaInitiated CoverageBuy$92.50N/AView Rating Details
(Data available from 2/19/2016 forward)

Earnings

Henry Schein (NASDAQ:HSIC) Earnings History and Estimates Chart

Earnings by Quarter for Henry Schein (NASDAQ:HSIC)

Henry Schein (NASDAQ HSIC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/20/2018$0.97N/AView Earnings Details
11/6/2017Q3 2017$0.90$0.87$3.05 billion$3.16 billionViewN/AView Earnings Details
8/8/2017Q2 17$0.87$0.88$3.05 billion$3.06 billionViewListenView Earnings Details
5/9/2017Q1 17$0.83$0.88$2.83 billion$2.92 billionViewListenView Earnings Details
2/21/2017Q416$0.93$0.94$3.08 billion$3.12 billionViewListenView Earnings Details
11/2/2016Q316$0.83$0.84$2.88 billion$2.87 billionViewN/AView Earnings Details
8/4/2016Q216$0.82$0.82$2.85 billion$2.87 billionViewN/AView Earnings Details
5/3/2016Q116$0.70$0.71$2.66 billion$2.70 billionViewListenView Earnings Details
2/10/2016Q415$0.83$0.84$2.82 billion$2.90 billionViewListenView Earnings Details
11/4/2015Q315$0.74$0.78$2.70 billion$2.70 billionViewListenView Earnings Details
7/29/2015Q215$0.73$0.73$2.68 billion$2.60 billionViewListenView Earnings Details
5/4/2015Q1$0.64$0.64$2.54 billion$25.00 billionViewListenView Earnings Details
2/11/2015Q414$0.76$0.78$2.72 billion$2.70 billionViewListenView Earnings Details
11/6/2014Q314$0.66$0.67$2.55 billion$2.62 billionViewListenView Earnings Details
8/4/2014Q214$0.67$0.68$2.56 billion$2.60 billionViewListenView Earnings Details
5/6/2014Q1$0.57$0.59$2.43 billion$2.40 billionViewListenView Earnings Details
2/11/2014Q413$0.70$0.72$2.53 billion$2.50 billionViewListenView Earnings Details
11/5/2013Q313$0.61$0.61$2.37 billion$2.30 billionViewListenView Earnings Details
8/6/2013Q2 2013$0.62$0.62$2.39 billion$2.40 billionViewListenView Earnings Details
5/7/2013Q1 2013$0.54$0.53$2.25 billion$2.30 billionViewListenView Earnings Details
2/13/2013Q4 2012$0.61$0.63$2.40 billion$2.40 billionViewListenView Earnings Details
11/7/2012Q312$0.54$0.54$2.24 billion$2.23 billionViewN/AView Earnings Details
8/2/2012$0.55$0.56ViewN/AView Earnings Details
5/8/2012$0.46$0.49ViewN/AView Earnings Details
2/15/2012$0.56$0.58ViewN/AView Earnings Details
11/1/2011$0.50$0.50ViewN/AView Earnings Details
8/2/2011$0.50$0.51ViewN/AView Earnings Details
5/3/2011$0.40$0.41ViewN/AView Earnings Details
2/22/2011$0.48$0.50ViewN/AView Earnings Details
10/29/2010Q3 2010$0.44$0.47ViewN/AView Earnings Details
8/2/2010Q2 2010$0.43$0.45ViewN/AView Earnings Details
5/4/2010Q1 2010$0.35$0.37ViewN/AView Earnings Details
2/23/2010Q4 2009$0.46$0.47ViewN/AView Earnings Details
11/4/2009Q3 2009$0.41$0.40ViewN/AView Earnings Details
8/4/2009Q2 2009$0.38$0.41ViewN/AView Earnings Details
5/4/2009Q1 2009$0.29$0.32ViewN/AView Earnings Details
2/24/2009Q4 2008$0.44$0.45ViewN/AView Earnings Details
11/5/2008Q3 2008$0.38$0.39ViewN/AView Earnings Details
8/5/2008Q2 2008$0.34$0.36ViewN/AView Earnings Details
5/6/2008Q1 2008$0.28$0.28ViewN/AView Earnings Details
2/25/2008Q4 2007$0.41$0.42ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Henry Schein (NASDAQ:HSIC) Earnings Estimates

2018 EPS Consensus Estimate: $3.94
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20185$0.92$1.02$0.95
Q2 20185$0.91$0.97$0.94
Q3 20185$0.85$1.14$0.98
Q4 20185$1.02$1.17$1.06
Q1 20191$1.02$1.02$1.02
Q2 20191$0.96$0.96$0.96
Q3 20191$1.14$1.14$1.14
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Henry Schein (NASDAQ:HSIC)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Henry Schein (NASDAQ HSIC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.19%
Institutional Ownership Percentage: 88.58%
Insider Trades by Quarter for Henry Schein (NASDAQ:HSIC)
Insider Trades by Quarter for Henry Schein (NASDAQ:HSIC)

Henry Schein (NASDAQ HSIC) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/1/2017Barry J AlperinDirectorSell5,796$70.76$410,124.9648,172View SEC Filing  
9/6/2017Paul RoseSVPSell2,126$172.51$366,756.2617,841View SEC Filing  
5/11/2017Gerald A BenjaminEVPSell12,578$175.10$2,202,407.8044,061View SEC Filing  
3/23/2017Lorelei McglynnSVPSell9,300$171.76$1,597,368.0033,048View SEC Filing  
3/20/2017Michael RacioppiSVPSell9,969$171.69$1,711,577.6133,057View SEC Filing  
3/17/2017Mark E MlotekEVPSell5,559$170.98$950,477.8240,426View SEC Filing  
3/8/2017James A HardingSVPSell10,552$171.60$1,810,723.2021,118View SEC Filing  
3/8/2017Philip A LaskawyDirectorSell1,103$171.51$189,175.5313,872View SEC Filing  
3/2/2017Michael S EttingerSVPSell6,960$171.09$1,190,786.4031,308View SEC Filing  
2/27/2017Donald J KabatDirectorSell4,334$173.62$752,469.0810,729View SEC Filing  
2/22/2017Paul RoseSVPSell6,821$173.24$1,181,670.0424,674View SEC Filing  
2/22/2017Steven PaladinoCFOSell13,072$173.40$2,266,684.8076,433View SEC Filing  
12/12/2016Kurt P KuehnDirectorBuy1,000$151.41$151,410.002,039View SEC Filing  
11/3/2016Mark E MlotekEVPSell2,417$155.19$375,094.2340,456View SEC Filing  
8/29/2016Paul BronsDirectorSell3,381$164.03$554,585.4313,715View SEC Filing  
6/2/2016Gerald A BenjaminEVPSell9,991$175.08$1,749,224.2854,885View SEC Filing  
5/16/2016James A HardingSVPSell10,302$172.60$1,778,125.2021,933View SEC Filing  
5/12/2016Peter M MccarthyInsiderSell1,158$171.75$198,886.5012,285View SEC Filing  
3/15/2016Lonnie ShoffCEOSell3,028$168.29$509,582.1231,000View SEC Filing  
3/14/2016David MckinleyInsiderSell3,339$167.92$560,684.8827,645View SEC Filing  
3/14/2016Norman S MatthewsDirectorSell5,335$167.75$894,946.2515,425View SEC Filing  
3/10/2016Donald J KabatDirectorSell1,218$168.38$205,086.843,189View SEC Filing  
3/7/2016Barry J AlperinDirectorSell1,635$167.36$273,633.6024,322View SEC Filing  
3/7/2016Michael S EttingerSVPSell5,423$168.13$911,768.9932,286View SEC Filing  
3/4/2016Philip A LaskawyDirectorSell1,317$166.88$219,780.9617,294View SEC Filing  
3/2/2016Louis W SullivanDirectorSell11,735$168.59$1,978,403.6516,830View SEC Filing  
3/2/2016Mark E MlotekEVPSell4,982$167.93$836,627.2645,149View SEC Filing  
2/26/2016Barry J AlperinDirectorSell7,540$167.96$1,266,418.4033,294View SEC Filing  
2/24/2016Robert MinowitzInsiderSell9,648$165.48$1,596,551.0425,788View SEC Filing  
2/22/2016Michael RacioppiSVPSell21,567$166.74$3,596,081.5849,866View SEC Filing  
2/17/2016Stanley KomaroffInsiderSell8,000$163.53$1,308,240.0031,694View SEC Filing  
2/16/2016Norman S MatthewsDirectorSell4,230$160.05$677,011.5017,122View SEC Filing  
2/12/2016Steven PaladinoCFOSell11,727$157.21$1,843,601.6783,602View SEC Filing  
2/11/2016Donald J. KabatDirectorSell6,637$156.36$1,037,761.325,938View SEC Filing  
12/17/2015Michael RacioppiSVPSell9,901$155.92$1,543,763.9228,299View SEC Filing  
12/10/2015Stanley M. BergmanCEOSell61,800$155.45$9,606,810.00152,926View SEC Filing  
11/9/2015Paul RoseSVPSell3,638$151.92$552,684.9619,223View SEC Filing  
11/5/2015Mark E. MlotekEVPSell2,952$155.00$457,560.0046,116View SEC Filing  
11/5/2015Stanley KomaroffInsiderSell6,297$154.89$975,342.3339,694View SEC Filing  
9/16/2015Philip A LaskawyDirectorSell4,000$136.20$544,800.0016,191View SEC Filing  
5/6/2015Paul BronsDirectorSell3,801$136.70$519,596.70View SEC Filing  
3/19/2015Michael S EttingerSVPSell4,352$139.75$608,192.00View SEC Filing  
3/18/2015James P BreslawskiCEOSell12,811$139.45$1,786,493.95View SEC Filing  
3/17/2015Leonard A DavidSVPSell3,935$140.00$550,900.00View SEC Filing  
3/16/2015Paul RoseSVPSell3,264$140.13$457,384.32View SEC Filing  
3/13/2015Norman S MatthewsDirectorSell9,200$136.07$1,251,844.00View SEC Filing  
3/11/2015Philip A LaskawyDirectorSell2,669$136.60$364,585.40View SEC Filing  
3/10/2015Donald J KabatDirectorSell2,002$138.00$276,276.00View SEC Filing  
3/5/2015Barry J AlperinDirectorSell6,637$140.64$933,427.68View SEC Filing  
2/24/2015Stanley KomaroffInsiderSell8,000$141.69$1,133,520.00View SEC Filing  
2/12/2015Donald J KabatDirectorSell5,000$142.68$713,400.00View SEC Filing  
2/12/2015Gerald A BenjaminEVPSell22,116$142.71$3,156,174.36View SEC Filing  
2/12/2015Robert MinowitzInsiderSell11,254$142.63$1,605,158.02View SEC Filing  
12/18/2014Leonard A DavidSVPSell3,557$135.34$481,404.38View SEC Filing  
12/9/2014Stanley M BergmanCEOSell69,600$135.56$9,434,976.00View SEC Filing  
12/8/2014Stanley M BergmanCEOSell23,485$136.34$3,201,944.90View SEC Filing  
11/24/2014Stanley KomaroffInsiderSell13,757$133.06$1,830,506.42View SEC Filing  
11/7/2014Lorelei McglynnSVPSell15,746$129.03$2,031,706.38View SEC Filing  
11/7/2014Mark E MlotekEVPSell6,262$128.75$806,232.50View SEC Filing  
9/2/2014Philip A LaskawyDirectorSell15,438$119.40$1,843,297.20View SEC Filing  
8/29/2014Louis W SullivanDirectorSell17,262$119.99$2,071,267.38View SEC Filing  
6/9/2014Barry J AlperinDirectorSell7,500$120.39$902,925.00View SEC Filing  
6/2/2014Gerald A BenjaminEVPSell12,354$119.50$1,476,303.00View SEC Filing  
5/28/2014Norman S MatthewsDirectorSell6,637$118.68$787,679.16View SEC Filing  
5/19/2014Donald KabatDirectorSell5,000$116.30$581,500.008,851View SEC Filing  
5/15/2014Paul BronsDirectorSell5,363$113.77$610,148.5113,851View SEC Filing  
3/19/2014Barry AlperinDirectorSell7,500$119.18$893,850.0025,104View SEC Filing  
3/17/2014Lonnie ShoffCEOSell3,722$119.06$443,141.3231,267View SEC Filing  
3/12/2014Michael EttingerSVPSell3,537$119.20$421,610.4031,760View SEC Filing  
3/11/2014David MckinleyInsiderSell2,387$119.65$285,604.5528,526View SEC Filing  
3/11/2014James BreslawskiCEOSell72,642$119.35$8,669,822.70113,936View SEC Filing  
3/11/2014Paul RoseSVPSell3,783$119.72$452,900.7620,229View SEC Filing  
3/10/2014Robert MinowitzInsiderSell11,553$119.98$1,386,128.9427,756View SEC Filing  
3/4/2014Donald KabatDirectorSell5,000$119.15$595,750.0012,159View SEC Filing  
2/28/2014Michael RacioppiSVPSell18,614$118.91$2,213,390.7430,667View SEC Filing  
2/26/2014Stanley KomaroffInsiderSell18,000$119.36$2,148,480.0059,796View SEC Filing  
2/25/2014Mark MlotekEVPSell20,333$119.16$2,422,880.2852,899View SEC Filing  
2/20/2014Steven PaladinoCFOSell28,757$117.79$3,387,287.0388,276View SEC Filing  
2/12/2014Philip LaskawyDirectorSell5,851$114.91$672,338.4115,982View SEC Filing  
12/19/2013Mark MlotekEVPSell22,004$111.97$2,463,787.8853,454View SEC Filing  
12/19/2013Michael RacioppiSVPSell29,257$111.97$3,275,906.2926,036View SEC Filing  
12/17/2013Gerald BenjaminEVPSell41,664$111.66$4,652,202.2466,887View SEC Filing  
12/17/2013James BreslawskiCEOSell57,754$111.91$6,463,250.14118,030View SEC Filing  
12/16/2013Steven PaladinoCFOSell47,652$112.31$5,351,796.1288,276View SEC Filing  
12/13/2013Stanley BergmanCEOSell78,000$111.90$8,728,200.00163,770View SEC Filing  
12/6/2013Leonard DavidSVPSell13,968$113.14$1,580,339.5220,620View SEC Filing  
11/26/2013Stanley KomaroffInsiderSell22,329$114.79$2,563,145.9159,796View SEC Filing  
8/23/2013Philip LaskawyDirectorSell21,637$103.17$2,232,289.2921,833View SEC Filing  
8/22/2013Norman MatthewsDirectorSell9,851$103.95$1,024,011.4521,782View SEC Filing  
8/20/2013Louis SullivanDirectorSell15,000$103.91$1,558,650.0020,987View SEC Filing  
8/12/2013Donald KabatDirectorSell2,500$106.25$265,625.0010,598View SEC Filing  
6/18/2013Barry J AlperinDirectorSell7,500$97.74$733,050.00View SEC Filing  
5/8/2013James A HardingCTOSell12,000$92.64$1,111,680.00View SEC Filing  
3/8/2013Donald J KabatDirectorSell4,038$90.00$363,420.00View SEC Filing  
12/4/2012Donald J KabatDirectorSell15,000$80.04$1,200,600.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Henry Schein (NASDAQ HSIC) News Headlines

Source:
DateHeadline
Henry Schein And Its Dental Laboratory Business, Zahn Dental, To Showcase The Companys Latest Digital Solutions At Chicago Midwinter Dental Meeting And LMT Lab DayHenry Schein And Its Dental Laboratory Business, Zahn Dental, To Showcase The Company's Latest Digital Solutions At Chicago Midwinter Dental Meeting And LMT Lab Day
www.prnewswire.com - February 19 at 8:34 AM
Crown Council Names Henry Schein Cares Its Humanitarian Partner Of The Year At 2018 Annual EventCrown Council Names Henry Schein Cares Its Humanitarian Partner Of The Year At 2018 Annual Event
www.prnewswire.com - February 19 at 8:34 AM
$0.97 EPS Expected for Henry Schein, Inc. (HSIC) This Quarter$0.97 EPS Expected for Henry Schein, Inc. (HSIC) This Quarter
www.americanbankingnews.com - February 19 at 7:26 AM
Stock Traders Buy High Volume of Put Options on Henry Schein (HSIC)Stock Traders Buy High Volume of Put Options on Henry Schein (HSIC)
www.americanbankingnews.com - February 16 at 7:26 AM
INVESTOR NOTICE: The Schall Law Firm Announces the Investigation of Securities Claims Against Henry Schein, Inc.INVESTOR NOTICE: The Schall Law Firm Announces the Investigation of Securities Claims Against Henry Schein, Inc.
finance.yahoo.com - February 15 at 4:45 PM
SHAREHOLDER ALERT: Pawar Law Group Announces Investigation of Securities Claims Against Henry Schein, Inc. - HSICSHAREHOLDER ALERT: Pawar Law Group Announces Investigation of Securities Claims Against Henry Schein, Inc. - HSIC
finance.yahoo.com - February 15 at 4:45 PM
Henry Schein (HSIC) Earns Neutral Rating from Analysts at JPMorgan Chase & Co.Henry Schein (HSIC) Earns Neutral Rating from Analysts at JPMorgan Chase & Co.
www.americanbankingnews.com - February 15 at 2:46 PM
Why the 2 Main Dental Supply Companies Just TankedWhy the 2 Main Dental Supply Companies Just Tanked
www.fool.com - February 14 at 10:46 PM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Henry Schein, Inc. (HSIC)SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Henry Schein, Inc. (HSIC)
finance.yahoo.com - February 14 at 4:56 PM
FTC Sues Dental Products Distributors for Alleged Conspiracy Not to Provide Discounts to a Customer Segment (HSIC) (PDCO)FTC Sues Dental Products Distributors for Alleged Conspiracy Not to Provide Discounts to a Customer Segment (HSIC) (PDCO)
www.streetinsider.com - February 14 at 9:19 AM
Johnson Fistel Investigates Henry Schein, Inc. and Patterson Companies, Inc ...Johnson Fistel Investigates Henry Schein, Inc. and Patterson Companies, Inc ...
www.prnewswire.com - February 13 at 4:17 PM
Henry Schein Shareholder Alert - HSIC Allegedly Involved In Dental Discount Conspiracy - Kehoe Law Firm, P.C. InvestigatingHenry Schein Shareholder Alert - HSIC Allegedly Involved In Dental Discount Conspiracy - Kehoe Law Firm, P.C. Investigating
finance.yahoo.com - February 13 at 4:17 PM
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Henry Schein, Inc.EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Henry Schein, Inc.
finance.yahoo.com - February 13 at 4:17 PM
Here's Why Henry Schein, Inc. Is Sinking TodayHere's Why Henry Schein, Inc. Is Sinking Today
finance.yahoo.com - February 13 at 4:17 PM
IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces the Investigation of Securities Claims Against Henry Schein, Inc.IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces the Investigation of Securities Claims Against Henry Schein, Inc.
finance.yahoo.com - February 13 at 4:17 PM
HENRY SCHEIN INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Henry Schein, Inc. To Contact The FirmHENRY SCHEIN INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Henry Schein, Inc. To Contact The Firm
finance.yahoo.com - February 13 at 4:17 PM
Henry Schein, Patterson Companies Stock Tumble on FTC ComplaintHenry Schein, Patterson Companies Stock Tumble on FTC Complaint
finance.yahoo.com - February 13 at 4:17 PM
Bragar Eagel & Squire, P.C. is Investigating Henry Schein, Inc. (HSIC) on Behalf of Stockholders and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. is Investigating Henry Schein, Inc. (HSIC) on Behalf of Stockholders and Encourages Investors to Contact the Firm
finance.yahoo.com - February 13 at 4:17 PM
INVESTOR ALERT: Investigation of Henry Schein Announced by Holzer & HolzerINVESTOR ALERT: Investigation of Henry Schein Announced by Holzer & Holzer
finance.yahoo.com - February 13 at 4:17 PM
Heres Why Henry Schein, Inc. Is Sinking TodayHere's Why Henry Schein, Inc. Is Sinking Today
www.fool.com - February 13 at 12:22 PM
Henry Schein (HSIC) Receives Hold Rating from Leerink SwannHenry Schein (HSIC) Receives Hold Rating from Leerink Swann
www.americanbankingnews.com - February 13 at 9:28 AM
Henry Schein Denies FTC Anti-Trust AllegationsHenry Schein Denies FTC Anti-Trust Allegations
www.prnewswire.com - February 13 at 7:05 AM
Henry Schein, Inc. (HSIC) Given Average Rating of "Hold" by BrokeragesHenry Schein, Inc. (HSIC) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - February 13 at 3:30 AM
Henry Schein (HSIC) Q4 Earnings to Show Growth in All Lines?Henry Schein (HSIC) Q4 Earnings to Show Growth in All Lines?
www.zacks.com - February 12 at 9:13 AM
Henry Schein, Inc. Named One Of The 2018 Worlds Most Ethical Companies® By The Ethisphere Institute For The Seventh TimeHenry Schein, Inc. Named One Of The 2018 World's Most Ethical Companies® By The Ethisphere Institute For The Seventh Time
finance.yahoo.com - February 12 at 9:13 AM
Henry Schein (HSIC) Set to Announce Earnings on MondayHenry Schein (HSIC) Set to Announce Earnings on Monday
www.americanbankingnews.com - February 12 at 3:02 AM
Henry Schein To Webcast Fourth Quarter And Full Year 2017 Conference Call On Tuesday, February 20, 2018 At 10:00 A.M. ETHenry Schein To Webcast Fourth Quarter And Full Year 2017 Conference Call On Tuesday, February 20, 2018 At 10:00 A.M. ET
finance.yahoo.com - February 6 at 9:17 AM
Henry Schein Animal Health To Showcase Products And Solutions And Host Live Events During VMX 2018Henry Schein Animal Health To Showcase Products And Solutions And Host Live Events During VMX 2018
finance.yahoo.com - February 2 at 9:19 AM
Henry Schein Commits $250,000 In Health Care Products To Americas Dentists Care Foundation In Support Of Free Oral Health Care For People In NeedHenry Schein Commits $250,000 In Health Care Products To America's Dentists Care Foundation In Support Of Free Oral Health Care For People In Need
finance.yahoo.com - January 31 at 9:40 AM
Henry Schein, Inc. (HSIC) Receives Average Recommendation of "Hold" from BrokeragesHenry Schein, Inc. (HSIC) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - January 19 at 3:58 AM
Henry Schein, Inc. (HSIC) Expected to Announce Quarterly Sales of $3.31 BillionHenry Schein, Inc. (HSIC) Expected to Announce Quarterly Sales of $3.31 Billion
www.americanbankingnews.com - January 18 at 8:38 AM
Henry Schein, Inc. (HSIC) Expected to Post Earnings of $0.97 Per ShareHenry Schein, Inc. (HSIC) Expected to Post Earnings of $0.97 Per Share
www.americanbankingnews.com - January 16 at 9:30 AM
Henry Schein (HSIC) Buys ABASE, Expands in Animal HealthHenry Schein (HSIC) Buys ABASE, Expands in Animal Health
finance.yahoo.com - January 15 at 11:06 AM
William Blair Weighs in on Henry Schein, Inc.s Q1 2018 Earnings (HSIC)William Blair Weighs in on Henry Schein, Inc.'s Q1 2018 Earnings (HSIC)
www.americanbankingnews.com - January 15 at 5:02 AM
Henry Schein, Inc. (HSIC) to Post Q3 2018 Earnings of $1.14 Per Share, William Blair ForecastsHenry Schein, Inc. (HSIC) to Post Q3 2018 Earnings of $1.14 Per Share, William Blair Forecasts
www.americanbankingnews.com - January 12 at 1:42 PM
Wired News – Henry Schein Buys Controlling Stake in Brazil’s Veterinary Health Care Products Distributor ABASEWired News – Henry Schein Buys Controlling Stake in Brazil’s Veterinary Health Care Products Distributor ABASE
finance.yahoo.com - January 10 at 11:29 AM
Henry Schein (HSIC) Acquires Majority Interest In ABASE - StreetInsider.comHenry Schein (HSIC) Acquires Majority Interest In ABASE - StreetInsider.com
www.streetinsider.com - January 9 at 11:09 AM
Henry Schein Buys 60% Stake In ABASE - Quick FactsHenry Schein Buys 60% Stake In ABASE - Quick Facts
www.nasdaq.com - January 8 at 3:45 PM
Henry Schein Acquires Majority Interest In ABASE, A Distributor Of Veterinary Health Care Products In Sao Paulo, BrazilHenry Schein Acquires Majority Interest In ABASE, A Distributor Of Veterinary Health Care Products In Sao Paulo, Brazil
finance.yahoo.com - January 8 at 8:36 AM
Henry Schein (HSIC) Raised to Hold at Zacks Investment ResearchHenry Schein (HSIC) Raised to Hold at Zacks Investment Research
www.americanbankingnews.com - January 7 at 8:50 PM
Henry Schein (HSIC) Receives New Coverage from Analysts at Evercore ISIHenry Schein (HSIC) Receives New Coverage from Analysts at Evercore ISI
www.americanbankingnews.com - January 4 at 5:04 PM
ETFs with exposure to Henry Schein, Inc. : January 2, 2018ETFs with exposure to Henry Schein, Inc. : January 2, 2018
finance.yahoo.com - January 2 at 3:58 PM
Henry Schein, Inc. (HSIC) Expected to Post Quarterly Sales of $3.31 BillionHenry Schein, Inc. (HSIC) Expected to Post Quarterly Sales of $3.31 Billion
www.americanbankingnews.com - January 1 at 2:12 PM
Investors Buy High Volume of Henry Schein Put Options (HSIC)Investors Buy High Volume of Henry Schein Put Options (HSIC)
www.americanbankingnews.com - December 31 at 4:22 AM
 Analysts Expect Henry Schein, Inc. (HSIC) Will Post Earnings of $0.97 Per Share Analysts Expect Henry Schein, Inc. (HSIC) Will Post Earnings of $0.97 Per Share
www.americanbankingnews.com - December 30 at 1:18 PM
Piper Jaffray Companies Reiterates "Buy" Rating for Henry Schein (HSIC)Piper Jaffray Companies Reiterates "Buy" Rating for Henry Schein (HSIC)
www.americanbankingnews.com - December 27 at 3:16 PM
Act-On Powers the Billion Dollar Publicly Traded EnterpriseAct-On Powers the Billion Dollar Publicly Traded Enterprise
www.businesswire.com - December 27 at 12:56 PM
Act-On signs on a pair of publicly traded billion-dollar clientsAct-On signs on a pair of publicly traded billion-dollar clients
finance.yahoo.com - December 27 at 12:56 PM
Henry Schein, Inc. (HSIC) Given Consensus Recommendation of "Hold" by BrokeragesHenry Schein, Inc. (HSIC) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - December 25 at 3:57 AM
ETFs with exposure to Henry Schein, Inc. : December 22, 2017ETFs with exposure to Henry Schein, Inc. : December 22, 2017
finance.yahoo.com - December 22 at 4:45 PM

SEC Filings

Henry Schein (NASDAQ:HSIC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Henry Schein (NASDAQ:HSIC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Henry Schein (NASDAQ HSIC) Stock Chart for Monday, February, 19, 2018

Loading chart…

This page was last updated on 2/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.